Travelers heading to Costa Rica’s Guanacaste Province are being urged to step up mosquito protection measures after the U.S. Centers for Disease Control and Prevention issued a Level 2 travel warning in response to an outbreak of chikungunya, a debilitating and currently incurable mosquito-borne virus.

Get the latest news straight to your inbox!

CDC Issues Travel Warning Over Deadly Mosquito Virus

According to recent updates on federal travel health notice pages and widely circulated news coverage, the CDC has raised its advisory level for Costa Rica’s Guanacaste Province to Level 2, which means travelers are advised to practice enhanced precautions. The move follows a marked increase in reported chikungunya infections in this Pacific coast region, home to some of the country’s busiest beach destinations and resort areas.

Publicly available information indicates that the advisory does not apply to all of Costa Rica, but specifically highlights Guanacaste as an area with notable transmission. The classification signals that health authorities are concerned about the intensity of the outbreak and the potential for visitors to become infected or carry the virus back to their home countries.

Level 2 notices are typically reserved for situations where there is sustained disease activity but routine travel has not been halted. Instead of recommending that travelers cancel trips, the current guidance emphasizes careful planning, strict mosquito bite prevention, and attention to any developing symptoms during and after travel.

Chikungunya: Debilitating, Incurable, and Spread by Day-Biting Mosquitoes

Chikungunya is caused by a virus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, the same species associated with dengue and Zika. Public health references describe the illness as sudden in onset, with high fever and severe joint pain that can be so intense it limits movement and daily activities.

While chikungunya is rarely fatal, reports from past outbreaks in the Caribbean, Latin America, Africa, and Asia show that the virus can lead to prolonged joint pain lasting months or even years. There is currently no licensed vaccine or specific antiviral treatment available, so management focuses on rest, fluids, and medications to reduce pain and fever.

Because there is no cure once infected and no widely available preventive shot, the disease is frequently characterized in media and health commentary as an incurable mosquito virus. Recovery is often complete but can be slow, and individuals with underlying medical conditions or older adults may face a higher risk of complications.

What the Advisory Means for Travelers Planning Trips to Costa Rica

The Level 2 warning does not prohibit travel to Costa Rica or Guanacaste, but it does signal that travelers should make mosquito avoidance a central part of their preparation. Guidance drawn from CDC travel health resources recommends using an EPA-registered insect repellent, wearing long sleeves and long pants when feasible, and choosing accommodations with air conditioning or window and door screens.

Travel medicine references also stress the importance of reducing mosquito breeding sites around lodgings, such as standing water in containers, and using bed nets in areas where screens or air conditioning are not reliable. These steps are particularly important during the daytime and early evening, when the Aedes mosquitoes that spread chikungunya are most active.

Travelers who develop fever, joint pain, headache, or rash during their trip or within about two weeks of returning are encouraged, according to general clinical guidance, to seek medical care and mention recent travel to Costa Rica. Early recognition helps clinicians distinguish chikungunya from other illnesses such as dengue, which can become severe and requires careful fluid management and monitoring.

Regional Context: Mosquito-Borne Disease Risk Across the Americas

The new chikungunya advisory in Costa Rica comes against a broader backdrop of elevated mosquito-borne disease activity across parts of the Americas. Surveillance summaries from U.S. and international health agencies over recent seasons have documented rising dengue case counts in several countries, as well as continued circulation of other arboviruses in tropical and subtropical regions.

Travel health notices for multiple destinations routinely highlight dengue, chikungunya, Zika, and malaria as key risks for international travelers, particularly during rainy or warmer months when mosquito populations expand. The Guanacaste outbreak fits into this wider pattern, reinforcing long-standing recommendations that travelers treat mosquito prevention as a core travel-safety measure rather than an afterthought.

Publicly available analytical reports also point out that travel-associated infections can seed limited local transmission in areas where competent mosquito vectors are present, including some parts of the continental United States. This possibility adds another layer of urgency to efforts to prevent infections among travelers returning from affected regions.

Practical Steps for Tourists and the Travel Industry

Tourism is a major economic driver for Costa Rica, and Guanacaste’s beaches, surf towns, and national parks draw visitors from North America and Europe throughout the year. The current advisory challenges both visitors and local businesses to adapt without bringing travel to a standstill.

Resorts, hotels, and tour operators in mosquito-prone destinations often respond to such situations by increasing outdoor spraying, improving drainage, and encouraging guests to use repellents and protective clothing. Travel industry updates and destination marketing materials are likely to begin highlighting mosquito-control efforts and health information more prominently as the season progresses.

For individual travelers, the latest guidance suggests reviewing destination-specific health advice as part of trip planning, packing effective repellents, and considering a pre-travel consultation, especially for pregnant people, older adults, or those with chronic medical conditions. Heightened awareness of chikungunya and other mosquito-borne viruses can help travelers make informed decisions while still enjoying Costa Rica’s natural attractions.